Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,388 | -11,489 | -8,466 | -5,701 | -2,467 |
| Depreciation Amortization | 15 | 47 | 11 | 16 | 7 |
| Other Working Capital | 507 | 151 | -215 | 391 | -68 |
| Other Operating Activity | 509 | 6,043 | 5,177 | 3,474 | 1,349 |
| Operating Cash Flow | $-1,357 | $-5,248 | $-3,493 | $-1,819 | $-1,179 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,961 | -15,494 | N/A | N/A | N/A |
| PPE Investments | -98 | -199 | -95 | -33 | -17 |
| Purchase Of Investment | -29 | -72 | -34 | -25 | -12 |
| Sale Of Investment | -4,705 | -10,104 | N/A | N/A | N/A |
| Other Investing Activity | -53 | -366 | -330 | -260 | -134 |
| Investing Cash Flow | $-2,924 | $-26,235 | $-459 | $-318 | $-163 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13 | 46,306 | 46,416 | -724 | N/A |
| Other Financing Activity | 0 | 3,761 | 3,761 | 3,768 | 3,761 |
| Financing Cash Flow | $13 | $50,067 | $50,176 | $3,044 | $3,761 |
| Exchange Rate Effect | N/A | -3 | -2 | 0 | N/A |
| Beginning Cash Position | 22,708 | 4,127 | 4,127 | 4,127 | 4,127 |
| End Cash Position | 18,440 | 22,708 | 50,350 | 5,033 | 6,551 |
| Net Cash Flow | $-4,268 | $18,581 | $46,223 | $907 | $2,425 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,357 | -5,248 | -3,493 | -1,819 | -1,179 |
| Capital Expenditure | -98 | -199 | -95 | -33 | -17 |
| Free Cash Flow | -1,455 | -5,447 | -3,587 | -1,852 | -1,196 |